Institutional Ownership An2 Therapeutics, Inc. (ANTX)
This table provides information about the institutional ownership of An2 Therapeutics, Inc. (ANTX). We have compiled data on the 38 institutions that hold shares in the stock, with a total of 13.8 Million shares, which have been reported (via 13F filing form) to have a value of $15.6 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
26,900
shares
|
$30,396
0.0% of portfolio
|
Q4 2024
Reduced 59.3%
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
26,630
shares
|
$30,091
0.0% of portfolio
|
Q1 2024
New holding
|
|
Integrated Wealth Concepts LLC
|
Feb 14, 2025 Q4 2024 |
25,000
shares
|
$28,249
0.0% of portfolio
|
Q3 2024
New holding
|
|
Private Advisor Group, LLC
|
Jan 31, 2025 Q4 2024 |
22,500
shares
|
$25,424
0.0% of portfolio
|
Q1 2024
New holding
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
10,185
shares
|
$11,509
0.0% of portfolio
|
Q4 2024
New holding
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Feb 13, 2025 Q4 2024 |
7,492
shares
|
$8,465
0.0% of portfolio
|
Q4 2024
Added 149.23%
|
|
ETF Managers Group, LLC
Summit, NJ |
Apr 17, 2023 Q1 2023 |
6,742
shares
|
$7,618
0.0% of portfolio
|
Q1 2023
New holding
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Feb 13, 2025 Q4 2024 |
1,463
shares
|
$1,653
0.0% of portfolio
|
Q4 2024
Reduced 65.63%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
300
shares
|
$338
0.0% of portfolio
|
Q4 2024
Reduced 0.99%
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Feb 07, 2025 Q4 2024 |
300
shares
|
$338
0.0% of portfolio
|
Q4 2023
Added 50.0%
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Feb 05, 2025 Q4 2024 |
200
shares
|
$225
0.0% of portfolio
|
Q4 2024
New holding
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
52
shares
|
$58
0.0% of portfolio
|
Q4 2024
Reduced 3.7%
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|